当前位置: 首页 > 期刊 > 《世界中医药》 > 20171
编号:13621598
MMPs和TIMPs与糖尿病心肌病心室重构的关系及糖心宁的干预作用(4)
http://www.100md.com 2017年1月1日 《世界中医药》 20171
     [7]Liu Wen-qi,Dai Hong-yan,Xing Ming-qingetal.Establishiment of animal models of diabetic cardiomyopathy[J].Chinese Journal of Tissue Engineering Research,2015,19(27):4265-4270.

    [8]Huynh K,Bernardo BC,McMullen JR,et al.Dibetic cardiomyopathy:mechanisms and new treatment strategies targeting antioxidant signaling pathways[J].Pharmacol Ther,2014,142(3):375-415.

    [9]Joshi M,Kotha SR,Malireddy S,et al.Conundrum of pathogenesis of diabetic cardiomyopathy:role of vascular endothelial dysfunction,reactive oxygen species,and mitochondria[J].Mol Cell Biochem,2014,386(1/2):233-249.

    [10]張建,华绮.代谢综合征[M].北京:人民卫生出版社,2003:23-28,92-98.

    [11]Peterson JT,LiH,Bryant JW.Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infracted rat[J].Cardiovase Res,2004,6:307-315.

    [12]Visser,NagaseH.Matrix Metalloproteinases and tissue inhibitors of metalloproteinases:structure,function and biochemistry[J].Circulation Research,2003,92(8):827-839.

    [13]王海颖,陈城,陆敏,等.怡心饮对糖尿病心脏病大鼠心肌CTGF-mRNA和MCP-1mRNA表达的影响[J].中西医结合心脑血管病杂志,2012,10(9):1086-1088.

    [14]郑永钿,缪英年,林泽宏.益气化瘀汤对糖尿病心肌病大鼠心肌细胞纤维化的影响[J].中国医药指南,2014,12(15):67-68.

    (2016-12-20收稿 责任编辑:洪志强), http://www.100md.com(谷玉红 李景 王军)
上一页1 2 3 4